Nova Biomedical Haemoglobin/Haematocrit ...
The StatStrip haemoglobin and haematocrit meter system is the only point of care (POC) system to provide anaemia screening and monitoring with measured, not calculated Hb and Hct (red cell volume) tests. This important breakthrough is possible because of new, patented electrochemical technologies developed by Nova Biomedical. Along with tiny fingerprick capillary samples (1.6 μL) and results in 40 seconds, StatStrip Hb/Hct improves clinical decision making at the point of care.
Accurate assessment of anaemia: Accurate anaemia evaluation requires both measured Hct and measured Hb. However, current POC meters only provide a calculated estimate of Hct. Calculated Hct assumes a normal Hct-to-Hb relationship [Hct % = 3 x Hb (g/L)] and is therefore inaccurate whenever Hct is abnormal. This is particularly evident in red cell structural abnormalities, haemoglobinopathies and haemolytic conditions caused by infection, autoimmune disease, toxins, drugs and chemicals. These conditions make measuring Hct a necessity, as calculated results can negatively impact treatment.
Small sample: StatStrip Hb/Hct uses a 1.6 μL fingerprick capillary blood sample, making routine Hb and Hct testing and anaemia screening virtually painless for the patient. It also enables frequent monitoring of blood loss in acute patients.
Economical Hb and Hct testing: Fingerprick capillary sampling eliminates costly blood drawing supplies, venous phlebotomy and lab testing. Combined with a single-use, low cost biosensor, StatStrip Hb/Hct offers economical POC Hb/Hct testing in many healthcare settings, including:
Complete Data Connectivity: StatStrip Hb/Hct offers both hardwired and wireless bi-directional connectivity for data integration with patient records. Features include:
To contact Nova Bio Medical ANZ about Nova Biomedical Haemoglobin/Haematocrit Testing - StatStrip® use Get a quote.
The StatStrip haemoglobin and haematocrit meter system is the only point of care (POC) system to provide anaemia screening and monitoring with measured, not calculated Hb and Hct (red cell volume) tests. This important breakthrough is possible because of new, patented electrochemical technologies developed by Nova Biomedical. Along with tiny fingerprick capillary samples (1.6 μL) and results in 40 seconds, StatStrip Hb/Hct improves clinical decision making at the point of care.
Accurate assessment of anaemia: Accurate anaemia evaluation requires both measured Hct and measured Hb. However, current POC meters only provide a calculated estimate of Hct. Calculated Hct assumes a normal Hct-to-Hb relationship [Hct % = 3 x Hb (g/L)] and is therefore inaccurate whenever Hct is abnormal. This is particularly evident in red cell structural abnormalities, haemoglobinopathies and haemolytic conditions caused by infection, autoimmune disease, toxins, drugs and chemicals. These conditions make measuring Hct a necessity, as calculated results can negatively impact treatment.
Small sample: StatStrip Hb/Hct uses a 1.6 μL fingerprick capillary blood sample, making routine Hb and Hct testing and anaemia screening virtually painless for the patient. It also enables frequent monitoring of blood loss in acute patients.
Economical Hb and Hct testing: Fingerprick capillary sampling eliminates costly blood drawing supplies, venous phlebotomy and lab testing. Combined with a single-use, low cost biosensor, StatStrip Hb/Hct offers economical POC Hb/Hct testing in many healthcare settings, including:
Complete Data Connectivity: StatStrip Hb/Hct offers both hardwired and wireless bi-directional connectivity for data integration with patient records. Features include:
To contact Nova Bio Medical ANZ about Nova Biomedical Haemoglobin/Haematocrit Testing - StatStrip® use Get a quote.
Thanks for your help!
Sorry! Unable to submit your request at this time. Please try again later.
Report this product